¾ÅÉ«ÊÓƵ

The TARGET Registry is an investigator-initiated prospective, multi center US registry of patients treated exclusively with Target 360 and Helical Detachable Coils led by Dr. Osama Zaidat at Mercy Health St. Vincent Hospital.

The ULTRA Registry is an investigator-initiated prospective, multicenter US registry of patients with small (<5mm) intracranial aneurysms treated exclusively with Target Ultra and Nano Detachable Coils led by Dr. Gaurav Jindal at the University of Maryland.

The ATLAS IDE study has shown excellent results from the largest to date pivotal data with high complete occlusion and low complication rates.

The ATLAS Y-stenting subset is the largest to date retrospective subset analysis of a single-arm trial which evaluates Y-stenting treatments of bifuraction aneurysms.*

One-year follow-up study on the Target Tetra Detachable Coil demonstrated excellent outcomes in the treatment of small spaces as well as filling and finishing in aneurysms of different sizes and morphologies.

With 6 key clinical studies and counting, the Contour Neurovascular System is proven to be effective in the treatment of aneurysms.

Designed for ease of use and optimized flow diversion, the Surpass Evolve Flow Diverter has been demonstrating strong efficacy and favorable safety data in the treatment of unruptured intracranial aneurysms around the world.

The ASSIST Registry is a core lab adjudicated study which captured real-world data from 1,500 subjects across 71 sites worldwide using Stryker’s Total Stroke Portfolio.